Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Ablation of brainstem C1 neurons improves cardiac function in volume overload heart failure.

Andrade DC, Toledo C, Díaz HS, Lucero C, Arce-Álvarez A, Oliveira LM, Takakura AC, Moreira TS, Schultz HD, Marcus NJ, Alcayaga J, Del Rio R.

Clin Sci (Lond). 2019 Jan 9. pii: CS20180589. doi: 10.1042/CS20180589. [Epub ahead of print]

PMID:
30626730
2.

Curcumin Improves Exercise Performance of Mice with Coronary Artery Ligation Induced HFrEF: Nrf2 and Antioxidant Mechanisms in Skeletal Muscle.

Wafi AM, Hong J, Rudebush TL, Yu L, Hackfort BT, Wang HJ, Schultz HD, Zucker IH, Gao L.

J Appl Physiol (1985). 2018 Nov 21. doi: 10.1152/japplphysiol.00654.2018. [Epub ahead of print]

PMID:
30462567
3.

Chronic Heart Failure Abolishes Circadian Rhythms in Resting and Chemoreflex Breathing.

Lewis R, Hackfort BT, Schultz HD.

Adv Exp Med Biol. 2018;1071:129-136. doi: 10.1007/978-3-319-91137-3_16.

PMID:
30357743
4.

Advances in cellular and integrative control of oxygen and carbon dioxide homeostasis.

Schultz HD.

J Physiol. 2018 Aug;596(15):2933-2934. doi: 10.1113/JP276326. No abstract available.

PMID:
30239019
5.

Visualizing data in research articles.

Schultz HD.

J Physiol. 2018 Aug;596(16):3431-3432. doi: 10.1113/JP276501. No abstract available.

PMID:
30133812
6.

Sympatho-excitatory response to pulmonary chemosensitive spinal afferent activation in anesthetized, vagotomized rats.

Shanks J, Xia Z, Lisco SJ, Rozanski GJ, Schultz HD, Zucker IH, Wang HJ.

Physiol Rep. 2018 Jun;6(12):e13742. doi: 10.14814/phy2.13742.

7.

Revisiting the physiological effects of exercise training on autonomic regulation and chemoreflex control in heart failure: does ejection fraction matter?

Andrade DC, Arce-Alvarez A, Toledo C, Díaz HS, Lucero C, Quintanilla RA, Schultz HD, Marcus NJ, Amann M, Del Rio R.

Am J Physiol Heart Circ Physiol. 2018 Mar 1;314(3):H464-H474. doi: 10.1152/ajpheart.00407.2017. Epub 2017 Nov 22. Review.

PMID:
29167119
8.

KLF2 mediates enhanced chemoreflex sensitivity, disordered breathing and autonomic dysregulation in heart failure.

Marcus NJ, Del Rio R, Ding Y, Schultz HD.

J Physiol. 2018 Aug;596(15):3171-3185. doi: 10.1113/JP273805. Epub 2017 Oct 11.

PMID:
29023738
9.

The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology.

van Bilsen M, Patel HC, Bauersachs J, Böhm M, Borggrefe M, Brutsaert D, Coats AJS, de Boer RA, de Keulenaer GW, Filippatos GS, Floras J, Grassi G, Jankowska EA, Kornet L, Lunde IG, Maack C, Mahfoud F, Pollesello P, Ponikowski P, Ruschitzka F, Sabbah HN, Schultz HD, Seferovic P, Slart RHJA, Taggart P, Tocchetti CG, Van Laake LW, Zannad F, Heymans S, Lyon AR.

Eur J Heart Fail. 2017 Nov;19(11):1361-1378. doi: 10.1002/ejhf.921. Epub 2017 Sep 26. Review.

10.

Carotid Body-Mediated Chemoreflex Drive in The Setting of low and High Output Heart Failure.

Del Rio R, Andrade DC, Toledo C, Diaz HS, Lucero C, Arce-Alvarez A, Marcus NJ, Schultz HD.

Sci Rep. 2017 Aug 14;7(1):8035. doi: 10.1038/s41598-017-08142-3.

11.

Exercise training improves cardiac autonomic control, cardiac function, and arrhythmogenesis in rats with preserved-ejection fraction heart failure.

Andrade DC, Arce-Alvarez A, Toledo C, Díaz HS, Lucero C, Schultz HD, Marcus NJ, Del Rio R.

J Appl Physiol (1985). 2017 Sep 1;123(3):567-577. doi: 10.1152/japplphysiol.00189.2017. Epub 2017 Jun 15.

12.

Cardiac diastolic and autonomic dysfunction are aggravated by central chemoreflex activation in heart failure with preserved ejection fraction rats.

Toledo C, Andrade DC, Lucero C, Arce-Alvarez A, Díaz HS, Aliaga V, Schultz HD, Marcus NJ, Manríquez M, Faúndez M, Del Rio R.

J Physiol. 2017 Apr 15;595(8):2479-2495. doi: 10.1113/JP273558. Epub 2017 Mar 19.

13.

Epigenetic influences on carotid body function: a new snag in the road to treating sleep apnoea.

Schultz HD.

J Physiol. 2017 Feb 1;595(3):629-630. doi: 10.1113/JP273289. No abstract available.

14.

Contribution of peripheral and central chemoreceptors to sympatho-excitation in heart failure.

Toledo C, Andrade DC, Lucero C, Schultz HD, Marcus N, Retamal M, Madrid C, Del Rio R.

J Physiol. 2017 Jan 1;595(1):43-51. doi: 10.1113/JP272075. Epub 2016 Jun 19. Review.

15.

Translational neurocardiology: preclinical models and cardioneural integrative aspects.

Ardell JL, Andresen MC, Armour JA, Billman GE, Chen PS, Foreman RD, Herring N, O'Leary DS, Sabbah HN, Schultz HD, Sunagawa K, Zucker IH.

J Physiol. 2016 Jul 15;594(14):3877-909. doi: 10.1113/JP271869. Epub 2016 Jun 17. Review.

16.

Relevance of the Carotid Body Chemoreflex in the Progression of Heart Failure.

Andrade DC, Lucero C, Toledo C, Madrid C, Marcus NJ, Schultz HD, Del Rio R.

Biomed Res Int. 2015;2015:467597. doi: 10.1155/2015/467597. Epub 2015 Dec 8. Review.

17.

Exercise training normalizes renal blood flow responses to acute hypoxia in experimental heart failure: role of the α1-adrenergic receptor.

Pügge C, Mediratta J, Marcus NJ, Schultz HD, Schiller AM, Zucker IH.

J Appl Physiol (1985). 2016 Feb 1;120(3):334-43. doi: 10.1152/japplphysiol.00320.2015. Epub 2015 Nov 25.

18.

Role of the Carotid Body Chemoreflex in the Pathophysiology of Heart Failure: A Perspective from Animal Studies.

Schultz HD, Marcus NJ, Del Rio R.

Adv Exp Med Biol. 2015;860:167-85. doi: 10.1007/978-3-319-18440-1_19. Review.

PMID:
26303479
19.

In adult female hamsters hypothyroidism stimulates D1 receptor-mediated breathing without altering D1 receptor expression.

Schlenker EH, Del Rio R, Schultz HD.

Respir Physiol Neurobiol. 2015 Nov;218:32-9. doi: 10.1016/j.resp.2015.07.011. Epub 2015 Jul 29.

20.

Editorial: Carotid body: a new target for rescuing neural control of cardiorespiratory balance in disease.

Del Rio R, Iturriaga R, Schultz HD.

Front Physiol. 2015 Jun 29;6:181. doi: 10.3389/fphys.2015.00181. eCollection 2015. No abstract available.

21.

Commentaries on Viewpoint: Precedence and autocracy in breathing control.

Torday JS, Zuo L, Chuang CC, Huszczuk A, Poon CS, Del Rio R, Andrade DC, Schultz HD, Nicolò A, Sacchetti M, Marcora SM, Ward SA.

J Appl Physiol (1985). 2015 Jun 15;118(12):1557-9. doi: 10.1152/japplphysiol.00229.2015. No abstract available.

22.

Exercise training attenuates chemoreflex-mediated reductions of renal blood flow in heart failure.

Marcus NJ, Pügge C, Mediratta J, Schiller AM, Del Rio R, Zucker IH, Schultz HD.

Am J Physiol Heart Circ Physiol. 2015 Jul 15;309(2):H259-66. doi: 10.1152/ajpheart.00268.2015. Epub 2015 May 22.

23.

Modulation of angiotensin II signaling following exercise training in heart failure.

Zucker IH, Schultz HD, Patel KP, Wang H.

Am J Physiol Heart Circ Physiol. 2015 Apr 15;308(8):H781-91. doi: 10.1152/ajpheart.00026.2015. Epub 2015 Feb 13. Review.

24.

Central role of carotid body chemoreceptors in disordered breathing and cardiorenal dysfunction in chronic heart failure.

Marcus NJ, Del Rio R, Schultz HD.

Front Physiol. 2014 Nov 24;5:438. doi: 10.3389/fphys.2014.00438. eCollection 2014.

25.

Selective carotid body ablation in experimental heart failure: a new therapeutic tool to improve cardiorespiratory control.

Del Rio R, Andrade DC, Marcus NJ, Schultz HD.

Exp Physiol. 2015 Feb 1;100(2):136-42. doi: 10.1113/expphysiol.2014.079566. Epub 2015 Jan 6. Review.

26.

Mechanisms of carotid body chemoreflex dysfunction during heart failure.

Schultz HD, Marcus NJ, Del Rio R.

Exp Physiol. 2015 Feb 1;100(2):124-9. doi: 10.1113/expphysiol.2014.079517. Epub 2015 Jan 15. Review.

27.

The arterial chemoreflex and cardiac stress in heart failure: nothing to be sheepish about.

Schultz HD.

Exp Physiol. 2014 Aug;99(8):1029-30. doi: 10.1113/expphysiol.2014.081299. No abstract available.

28.

Reply from Noah J. Marcus, Rodrigo Del Rio and Harold D. Schultz.

Marcus NJ, Del Rio R, Schultz HD.

J Physiol. 2014 Apr 15;592(8):1905-6. doi: 10.1113/jphysiol.2014.273565. No abstract available.

29.

Simvastatin treatment attenuates increased respiratory variability and apnea/hypopnea index in rats with chronic heart failure.

Haack KK, Marcus NJ, Del Rio R, Zucker IH, Schultz HD.

Hypertension. 2014 May;63(5):1041-9. doi: 10.1161/HYPERTENSIONAHA.113.02535. Epub 2014 Feb 10.

30.

Hypothyroidism affects D2 receptor-mediated breathing without altering D2 receptor expression.

Schlenker EH, Del Rio R, Schultz HD.

Respir Physiol Neurobiol. 2014 Mar 1;193:29-37. doi: 10.1016/j.resp.2014.01.005. Epub 2014 Jan 13.

31.

Over-expressed copper/zinc superoxide dismutase localizes to mitochondria in neurons inhibiting the angiotensin II-mediated increase in mitochondrial superoxide.

Li S, Case AJ, Yang RF, Schultz HD, Zimmerman MC.

Redox Biol. 2013 Nov 18;2:8-14. doi: 10.1016/j.redox.2013.11.002. eCollection 2013.

32.

Carotid body denervation improves autonomic and cardiac function and attenuates disordered breathing in congestive heart failure.

Marcus NJ, Del Rio R, Schultz EP, Xia XH, Schultz HD.

J Physiol. 2014 Jan 15;592(2):391-408. doi: 10.1113/jphysiol.2013.266221. Epub 2013 Nov 18.

33.

Carotid chemoreceptor ablation improves survival in heart failure: rescuing autonomic control of cardiorespiratory function.

Del Rio R, Marcus NJ, Schultz HD.

J Am Coll Cardiol. 2013 Dec 24;62(25):2422-2430. doi: 10.1016/j.jacc.2013.07.079. Epub 2013 Sep 4.

34.

Role of the carotid body in the pathophysiology of heart failure.

Schultz HD, Marcus NJ, Del Rio R.

Curr Hypertens Rep. 2013 Aug;15(4):356-62. doi: 10.1007/s11906-013-0368-x. Review.

35.

Inhibition of hydrogen sulfide restores normal breathing stability and improves autonomic control during experimental heart failure.

Del Rio R, Marcus NJ, Schultz HD.

J Appl Physiol (1985). 2013 May;114(9):1141-50. doi: 10.1152/japplphysiol.01503.2012. Epub 2013 Feb 28.

36.

Heart failure and carotid body chemoreception.

Schultz HD, Marcus NJ.

Adv Exp Med Biol. 2012;758:387-95. doi: 10.1007/978-94-007-4584-1_52. Review.

PMID:
23080187
37.

The paradox of carbon monoxide and the heart.

Schultz HD.

Am J Respir Crit Care Med. 2012 Oct 1;186(7):582-3. doi: 10.1164/rccm.201207-1341ED. No abstract available.

PMID:
23027850
38.

Be sympathetic to your nervous system.

Zucker IH, Patel KP, Schultz HD.

J Appl Physiol (1985). 2012 Oct 15;113(8):1292-3. doi: 10.1152/japplphysiol.00911.2012. Epub 2012 Aug 2. No abstract available.

39.

Role of neurotransmitter gases in the control of the carotid body in heart failure.

Schultz HD, Del Rio R, Ding Y, Marcus NJ.

Respir Physiol Neurobiol. 2012 Nov 15;184(2):197-203. doi: 10.1016/j.resp.2012.07.010. Epub 2012 Jul 25. Review.

40.

Effect of AT1 receptor blockade on intermittent hypoxia-induced endothelial dysfunction.

Marcus NJ, Philippi NR, Bird CE, Li YL, Schultz HD, Morgan BJ.

Respir Physiol Neurobiol. 2012 Aug 15;183(2):67-74. doi: 10.1016/j.resp.2012.05.025. Epub 2012 Jun 21.

41.

Angiotensin peptides and nitric oxide in cardiovascular disease.

Patel KP, Schultz HD.

Antioxid Redox Signal. 2013 Oct 1;19(10):1121-32. doi: 10.1089/ars.2012.4614. Epub 2012 May 21. Review.

42.

Neurohumoral stimulation.

Zucker IH, Patel KP, Schultz HD.

Heart Fail Clin. 2012 Jan;8(1):87-99. doi: 10.1016/j.hfc.2011.08.007. Review.

43.

Hypothyroidism stimulates D2 receptor-mediated breathing in response to acute hypoxia and alters D2 receptors levels in carotid bodies and brain.

Schlenker EH, Schultz HD.

Respir Physiol Neurobiol. 2012 Jan 15;180(1):69-78. doi: 10.1016/j.resp.2011.10.013. Epub 2011 Oct 25.

44.

Hypothyroidism attenuates SCH 23390-mediated depression of breathing and decreases D1 receptor expression in carotid bodies, PVN and striatum of hamsters.

Schlenker EH, Schultz HD.

Brain Res. 2011 Jul 15;1401:40-51. doi: 10.1016/j.brainres.2011.05.034. Epub 2011 May 23.

45.

Angiotensin and carotid body chemoreception in heart failure.

Schultz HD.

Curr Opin Pharmacol. 2011 Apr;11(2):144-9. doi: 10.1016/j.coph.2010.12.004. Epub 2011 Jan 15. Review.

46.

Role of blood flow in carotid body chemoreflex function in heart failure.

Ding Y, Li YL, Schultz HD.

J Physiol. 2011 Jan 1;589(Pt 1):245-58. doi: 10.1113/jphysiol.2010.200584. Epub 2010 Nov 15.

47.

Angiotensin-(1-7) increases neuronal potassium current via a nitric oxide-dependent mechanism.

Yang RF, Yin JX, Li YL, Zimmerman MC, Schultz HD.

Am J Physiol Cell Physiol. 2011 Jan;300(1):C58-64. doi: 10.1152/ajpcell.00369.2010. Epub 2010 Oct 27.

48.

The attenuation of central angiotensin II-dependent pressor response and intra-neuronal signaling by intracarotid injection of nanoformulated copper/zinc superoxide dismutase.

Rosenbaugh EG, Roat JW, Gao L, Yang RF, Manickam DS, Yin JX, Schultz HD, Bronich TK, Batrakova EV, Kabanov AV, Zucker IH, Zimmerman MC.

Biomaterials. 2010 Jul;31(19):5218-26. doi: 10.1016/j.biomaterials.2010.03.026. Epub 2010 Apr 7.

49.

Expression of neuronal nitric oxide synthase in rabbit carotid body glomus cells regulates large-conductance Ca2+-activated potassium currents.

Li YL, Zheng H, Ding Y, Schultz HD.

J Neurophysiol. 2010 Jun;103(6):3027-33. doi: 10.1152/jn.01138.2009. Epub 2010 Mar 31.

50.

Chronic intermittent hypoxia augments chemoreflex control of sympathetic activity: role of the angiotensin II type 1 receptor.

Marcus NJ, Li YL, Bird CE, Schultz HD, Morgan BJ.

Respir Physiol Neurobiol. 2010 Apr 15;171(1):36-45. doi: 10.1016/j.resp.2010.02.003. Epub 2010 Feb 12.

Supplemental Content

Loading ...
Support Center